Phase I clinical trial of PAC-1 in patients with end-stage cancers shows promising re

[News]

A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers.

More... (https://www.news-medical.net/news/20221222/Phase-I-clinical-trial-of-PAC-1-in-patients-with-end-stage-cancers-shows-promising-results.aspx)